CD45 Antibody (C-term) Blocking Peptide

CD45 Antibody (C-term) Blocking Peptide

€363.00
In stock
SKU
AC-BP1620a
Catalog Number: AC-BP1620a
Size: 500 µg
Datasheet
Request Information
Background:
CD45 is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an extracellular domain, a single transmembrane segment and two tandem intracytoplasmic catalytic domains, and thus belongs to receptor type PTP. The CD45 gene is specifically expressed in hematopoietic cells. This PTP has been shown to be an essential regulator of T- and B-cell antigen receptor signaling. It functions through either direct interaction with components of the antigen receptor complexes, or by activating various Src family kinases required for the antigen receptor signaling. This PTP also suppresses JAK kinases, and thus functions as a regulator of cytokine receptor signaling.

Other Names:
Receptor-type tyrosine-protein phosphatase C, Leukocyte common antigen, L-CA, T200, CD45, PTPRC, CD45

Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP1620a was selected from the C-term region of human CD45 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Gene Name: PTPRC (HGNC:9666)

Gene ID: 5788
Primary Accession: P08575
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
More Information
Is Featured? No
Write Your Own Review
You're reviewing:CD45 Antibody (C-term) Blocking Peptide